Every hair loss compound in clinical development. Every AGA compound in clinical development. Every AA compound in clinical development. No blogspam, just data.
| Compound | Phase | Type | ||||
|---|---|---|---|---|---|---|
| Ritlecitinib Litfulo | Approved | Oral | ||||
CompanyPfizer Statusapproved Est. ReleaseAvailable MechanismJAK3/TEC Inhibitor SummaryJAK inhibitor approved for alopecia areata (autoimmune). Does NOT work for male/female pattern baldness (AGA). Often confused but different conditions entirely. LatestFDA approved for alopecia areata (autoimmune hair loss). NOT for androgenetic alopecia. No curated threads. Search Reddit | ||||||
| Baricitinib Olumiant | Approved | Oral | ||||
CompanyEli Lilly Statusapproved Est. ReleaseAvailable MechanismJAK1/JAK2 Inhibitor SummaryAnother JAK inhibitor for alopecia areata. Like ritlecitinib, does NOT treat androgenetic alopecia. Systemic drug with immune effects. LatestFDA approved for alopecia areata. Also approved for rheumatoid arthritis. No curated threads. Search Reddit | ||||||
| Clascoterone Breezula / CB-03-01 / Winlevi | Phase 3 | Topical | ||||
CompanyCosmo Pharmaceuticals Statusactive Est. Release2027 MechanismAndrogen Receptor Antagonist SummaryTopical anti-androgen that blocks DHT at the scalp without systemic effects. 1% already FDA approved for acne (Winlevi). 5% concentration in Phase 3 (SCALP trials) showed dramatic hair count improvements - 539% and 168% relative improvement vs placebo with minimal systemic exposure. Would be first new AGA mechanism in 30+ years if approved. LatestPhase 3 SCALP 1 & 2 trials completed Dec 2025. 5% concentration showed 539% improvement (SCALP 1) and 168% improvement (SCALP 2) vs vehicle in Target Area Hair Count. 1,465 men enrolled. FDA/EMA submissions expected after spring 2026 safety follow-up completion. Reddit (4)Clascoterone 5% Delivers Strong Phase 3 Hair-Growth Results 2026-01-08 · 360 pts ·
r/tressless
Chat is this real? Compound called clascoterone 2025-12-11 · 577 pts ·
r/tressless
Currently Trending Twitter Post: Clascoterone Hailed as New Cure 2025-12-07 · 1890 pts ·
r/tressless
Breezula 6 Month Topline Phase III Results Released 2025-12-03 · 166 pts ·
r/tressless
| ||||||
| Pyrilutamide KX-826 / Koshine | Phase 3 | Topical | ||||
CompanyKintor Pharmaceutical Statusactive Est. ReleaseTBD MechanismAndrogen Receptor Antagonist SummaryTopical androgen receptor antagonist. Company-reported Phase 2-stage data in a pivotal Phase 2/3 trial met the primary endpoint vs placebo, with Phase 3-stage completion expected in early 2026. Final confirmatory data is still needed. LatestKintor press release (Jul 2025): Phase 2 stage of a pivotal Phase 2/3 trial met the primary endpoint vs placebo. Both 0.5% and 1.0% BID improved Target Area Hair Count and hair thickness at Week 24. Phase 3 stage enrollment completed (666 patients) and the trial is expected to complete in early 2026. Final Phase 3 results still pending. Reddit (4)KX-826 , a small change in the pipeline 2026-02-10 · 4 pts ·
r/tressless
Status update on upcoming treatments 2025-12-11 · 43 pts ·
r/tressless
[July 2025] Most Promising Hair Loss Treatments in Clinical Trials 2025-07-06 · 269 pts ·
r/tressless
Kintor Phase 2 Results released KX-826 (pyrilutamide) 2022-08-29 · 446 pts ·
r/tressless
| ||||||
| VDPHL01 Veradermics | Phase 3 | Oral | ||||
CompanyVeradermics Statusactive Est. Release2027-2028 MechanismExtended-Release Minoxidil SummaryExtended-release oral minoxidil designed to reduce peak exposure vs immediate-release oral minoxidil. Non-hormonal approach (doesn't touch DHT). In Phase 3 development for pattern hair loss, with topline Phase 3 data expected in 2026 per company guidance. LatestCompany press release (Feb 2026): completed enrollment in the second pivotal Phase 3 trial for male pattern hair loss (~1,000 male patients across studies). Topline data expected 1H 2026 (initial trial) and 2H 2026 (confirmatory trial). Female Phase 2/3 trial recruiting (NCT07146022). Reddit (4)Veradermics completes enrollment in second Phase 3 trial for oral hair-loss drug 2026-02-09 · 18 pts ·
r/tressless
Upcoming New Treatments - Based on Phase 2025-12-28 · 52 pts ·
r/tressless
Veradermics + 47 hair/cm2 in only 4 months 2025-12-18 · 32 pts ·
r/tressless
Veradermics 150m series C funding 2025-10-16 · 34 pts ·
r/tressless
| ||||||
| Dutasteride Topical Solution 0.05% topical dutasteride | Phase 2 | Topical | ||||
CompanyShilpa Medicare Statusactive Est. ReleaseTBD Mechanism5-alpha Reductase Inhibitor (Type I & II) SummaryInvestigational topical dutasteride formulation designed to concentrate 5-alpha reductase inhibition in the scalp while limiting systemic DHT suppression. Phase 2 data suggests 0.05% may improve hair counts vs placebo and compare favorably to oral finasteride, but larger confirmatory trials and long-term safety are needed. LatestPhase 2, randomized controlled study (135 men, 24 weeks) comparing a novel dutasteride topical solution (0.05% and 0.01%) vs placebo and oral finasteride 1mg. 0.05% showed the largest improvements in Target Area Hair Count and hair thickness at Week 24, with modest changes in serum DHT/testosterone (CTRI/2021/03/032173). Funded by Shilpa Medicare; authors report a related patent filing. | ||||||
| GT20029 AR-PROTAC | Phase 2 | Topical | ||||
CompanyKintor Pharmaceutical Statusactive Est. Release2027-2028 MechanismPROTAC Androgen Receptor Degrader SummaryFirst-in-class PROTAC technology that degrades androgen receptors rather than just blocking them. Novel mechanism could be more effective than traditional anti-androgens. Phase 2 showed all treatment groups had hair count increases vs placebo. LatestPhase 2 complete. Phase 3 started 2025, expected to finish ~2026. Market release 2027-2028 if successful. | ||||||
| PP405 | Phase 2 | Topical | ||||
CompanyPelage Pharmaceuticals Statusactive Est. Release2028-2029 MechanismMitochondrial Pyruvate Carrier (MPC) Inhibitor SummaryNovel MPC inhibitor that reprograms hair follicle metabolism, pushing stem cells from oxidative phosphorylation into a glycolytic state (mimicking active growth phase). NOT an androgen blocker - works on men and women. Backed by ARCH Ventures and Google Ventures. Fast response in trials (8 weeks vs typical 6-12 months). LatestPhase 2a complete. BioSpace (Feb 2026) interview: first part of 2026 spent engaging with FDA to confirm Phase 3 trial design and endpoints; Phase III described as in planning stages. Full results still expected to be presented at a medical meeting (often rumored as AAD March 2026). Phase 3 enrollment previously stated as expected to begin mid-2026 per CMO Christina Weng (Jan 2026). Earlier Phase 2a data: 31% of men showed >20% hair density increase at 8 weeks (vs 0% placebo). No systemic absorption detected. $120M Series B funding secured. Reddit (9)Pelage are starting phase 3 for PP405 towards the end of 2026 2026-02-11 · 185 pts ·
r/tressless
PP405: Regrows Hair In 8 Weeks. Is This The Miracle Cure? 2026-02-01 · 139 pts ·
r/tressless
Pelage to present PP405 Phase 2a clinical trial full results at an upcoming medical meeting - CMO Christina Weng says 2026-01-25 · 736 pts ·
r/tressless
Upcoming New Treatments - Based on Phase 2025-12-28 · 53 pts ·
r/tressless
A comparison of PP405 versus ABS-201 2025-10-25 · 106 pts ·
r/tressless
Pelage Pharmaceuticals has secured $120 million in funding 2025-10-15 · 400 pts ·
r/tressless
Don't Get Too Hyped About PP405. We've Seen This Movie Before. 2025-06-18 · 219 pts ·
r/tressless
PP405 Phase 2a press release with early results 2025-06-17 · 694 pts ·
r/tressless
UCLA scientists found a molecule — PP405 — that wakes up sleeping hair follicles 2025-05-12 · 1353 pts ·
r/tressless
| ||||||
| Verteporfin Visudyne | Phase 2 | Injectable | ||||
CompanyVarious (Off-label) Statusactive Est. ReleaseTBD MechanismYAP/TAZ Inhibitor (Scarless Healing) SummaryOriginally for eye disease, now being tested for scarless healing in hair transplants. Could enable unlimited donor harvesting by preventing scar formation. Potentially game-changing for transplant patients. LatestMulti-center trial recruitment ongoing. FDA approved for macular degeneration, being explored for scarless wound healing in transplants. | ||||||
| HMI-115 BAY-1158061 | Phase 2 | Subcutaneous Injection | ||||
CompanyBayer / Hope Medicine Statusactive Est. Release2027 MechanismProlactin Receptor Monoclonal Antibody SummaryMonoclonal antibody blocking prolactin receptors in hair follicles. Phase 1b showed +14 hairs/cm² over 24 weeks. Completely different mechanism from anti-androgens - targets PRLR pathway. Licensed from Bayer. Macaque monkey studies showed dramatic regrowth. LatestPhase 2 completed Nov 2024, results pending. Phase 1b showed +14 hairs/cm² in males. Company targeting 2027 release. Reddit (6)Upcoming New Treatments - Based on Phase 2025-12-28 · 53 pts ·
r/tressless
What's going on with hmi115? The Phase 2 was concluded Nov2024 but no news 2025-12-03 · 12 pts ·
r/tressless
Hope Medicine's HMI-115 could be out in 2027 per Company Founder 2025-05-25 · 35 pts ·
r/tressless
2-month HMI-115 results from the Chinese trial 2024-05-16 · 67 pts ·
r/tressless
HMI 115 Phase 2 - Leaked pics from Discord 2024-05-03 · 362 pts ·
r/tressless
HMI-115 update: Chime Biologics and Hope Medicine Enter Manufacturing Agreement 2023-10-27 · 109 pts ·
r/tressless
| ||||||
| DLQ01 | Phase 2 | Topical | ||||
CompanyDermaliq Therapeutics Statusactive Est. Release2028+ MechanismProstaglandin F2α Analog SummaryTopical prostaglandin F2α analog with proprietary hyliQ® carrier technology that delivers active ingredients directly into hair follicles. More direct than minoxidil - doesn't need enzyme conversion, works directly on PGF receptors to extend anagen phase. Can be stacked with minoxidil. LatestPhase 1b/2a completed July 2024. 12.3% TAHC increase (p=0.008), 83% response rate. Beat minoxidil (9.8%). For men and women. | ||||||
| Follicopeptide FOL-005 / FOL005 | Phase 2 | Topical | ||||
CompanyCoegin Pharma Statusactive Est. ReleaseCcosmetic MechanismOsteopontin Peptide (Stem Cell & Angiogenesis) SummaryModified osteopontin peptide that activates stem cells, promotes blood vessel growth around follicles. Launched as cosmetic (not drug) for faster market access. Trial results showed ~12 hairs/cm² increase after 4 months - comparable to finasteride. Originally developed by Follicum, acquired by Coegin Pharma. LatestNow commercially available as cosmetic product via Scandinavian Biolabs and Hårklinikken partnerships (€170 for 2 bottles). ~12 hairs/cm² increase in trials - similar to finasteride. | ||||||
| RU-58841 PSK-3841 / HMR-3841 | Phase 2 | Topical | ||||
CompanyRoussel Uclaf / ProStrakan Statusdiscontinued Est. ReleaseGray market MechanismNon-steroidal Androgen Receptor Antagonist SummaryTopical anti-androgen that blocks DHT at the receptor (unlike fin which blocks DHT production). Developed 1980s, trials abandoned ~2010. Related to nilutamide/bicalutamide. Popular in community but sold as 'research chemical' - no FDA approval, no quality control. LatestPhase 1/2 trials completed but abandoned ~2010. Now sold as gray market 'research chemical'. | ||||||
| AMP-303 SCUBE3 | Phase 1 | Injectable | ||||
CompanyAmplifica Statusactive Est. Release2028+ MechanismSignaling Molecule (Hair Follicle Activation) SummaryNovel polysaccharide intradermal injectable that activates dormant hair follicles using unique signaling molecules. Nature-inspired approach from UCI research. Phase 1 showed 15% hair increase in 60 days. Co-founded by hair transplant surgeon Dr. William Rassman. LatestPhase 1 completed Jan 2025. 15% increase in non-vellus hair at 60 days. Results presented at 2025 SID meeting. Co-founded by Dr. William Rassman (active on r/tressless). Reddit (3)Amplifica is working on 3 Programs: AMP-303 / AMP-203 & AMP-506 / AMP-601 2025-03-11 · 27 pts ·
r/tressless
Amplifica Sees Positive Results for Hair Loss Treatment - Results Show 15% increase in 60 days! 2025-01-15 · 102 pts ·
r/tressless
New drug for hair loss announced by Amplifica 2023-01-26 · 166 pts ·
r/tressless
| ||||||
| ET-02 | Phase 1 | Topical | ||||
CompanyEirion Therapeutics Statusactive Est. Release2028+ MechanismPAI-1 Inhibitor (Stem Cell Activation) SummaryPAI-1 inhibitor that targets stem cell biology to restore normal hair follicle function. Phase 1 showed 6-fold increase in non-vellus hair in just 5 weeks - outperformed 4 months of minoxidil. Also may reverse hair graying. Non-hormonal, no sexual side effects expected. Being tested in oral form too. LatestPhase 1 completed Jan 2025 with unprecedented results. 6-fold increase in hair count in 5 weeks. Phase 2 with ~150 participants planned for 2025. Reddit (3)Why does Pelage PP405 receive so much attention, while Eirion ET-02 seems forgotten? 2025-06-24 · 31 pts ·
r/tressless
I hope ET-02 or PP405 will be released in the next 4-5 years 2025-06-10 · 16 pts ·
r/tressless
Et-02 phase one clinic trial results successful! 2025-01-10 · 48 pts ·
r/tressless
| ||||||
| OLX104C OLX72021 | Phase 1 | Injectable | ||||
CompanyOliX Pharmaceuticals Statusactive Est. Release2027+ MechanismRNA Interference (Androgen Receptor silencing) SummaryKorean biotech using asymmetric siRNA (asiRNA) to silence androgen receptor expression in hair follicles. Unlike DHT blockers, targets the receptor itself. Injected locally into scalp, rapidly degrades in blood - potentially avoiding sexual dysfunction and depression. Single dose inhibits AR for 3+ weeks. LatestPhase 1 started June 2023 in Australia. Enrolling 120 men across 10 sites. 30-month trial. Scalp injection that degrades in blood - avoids systemic side effects. | ||||||
| ABS-201 | Preclinical | Subcutaneous Injection | ||||
CompanyAbSci Statusactive Est. Release2029-2030 MechanismProlactin Receptor Monoclonal Antibody SummaryAI-designed prolactin receptor antibody targeting PRLR. Preclinical: 100% regrowth in mice in 22 days (vs 5% minoxidil), extends growth phase 20-30%, expands stem cells, restores IGF-1/FGF-7, no shedding phase. Dosing every 3-6 months. Similar mechanism to HMI-115. LatestPhase 1/2a (HEADLINE trial) planned late 2025/early 2026. Overseen by Dr. Rodney Sinclair. Dosing every 3-6 months. Reddit (5)Upcoming New Treatments - Based on Phase 2025-12-28 · 53 pts ·
r/tressless
ABS-201 KOL Seminar: Dr. Ralf Paus on Human Ex Vivo Hair Regrowth Data 2025-12-23 · 16 pts ·
r/tressless
Absci ABS-201 Prolactin Blocking Injections: Phase 1 Trials Begin 2025-12-11 · 22 pts ·
r/tressless
A comparison of the two leading baldness treatments: PP405 versus ABS-201 2025-10-25 · 106 pts ·
r/tressless
Has anyone done research on Absci's AI-driven antibody platform? 2025-08-20 · 2 pts ·
r/tressless
| ||||||
| Hair Cloning YCH001 | Preclinical | Cell Therapy | ||||
CompanyYunce Medical Statusresearch Est. Release2027 MechanismiPSC-derived Hair Follicle Regeneration SummaryChinese biotech pursuing iPSC-derived hair follicle regeneration, similar to Stemson's approach. Claims >90% CD200 positive cell differentiation (vs 30% in literature). Based in Chengdu, partnered with West China Hospital. Positioning as Stemson's successor after their shutdown. LatestAnimal trials complete. Human clinical trials planned for 2026. Seeking $2M funding. Partnership with West China Hospital of Sichuan University. | ||||||
| 2-Deoxy-D-Ribose 2dDR / Deoxyribose Sugar | Preclinical | Topical | ||||
CompanyUniversity of Sheffield Statusresearch Est. ReleaseTBD MechanismAngiogenesis (Blood Vessel Formation) SummaryA naturally occurring sugar molecule (part of DNA backbone) that promotes blood vessel formation. Sheffield/COMSATS researchers noticed faster hair growth around healing wounds treated with 2dDR. Mouse study showed similar efficacy to minoxidil. Very early stage - researchers explicitly warned against companies selling it prematurely. LatestPublished June 2024 in Frontiers in Pharmacology. Mouse study showed 2dDR gel 80-90% as effective as minoxidil. Researchers cautioned against premature use - no human safety/efficacy data yet. Reddit (5)Novel Formulation To Put An End To Hair Loss Once And For All 2025-11-06 · 120 pts ·
r/tressless
7 months 2DDR treatment, photos 2025-10-01 · 7 pts ·
r/tressless
two months on 2-deoxy-d-ribose (2ddr) 2025-06-28 · 10 pts ·
r/tressless
2ddr thread, I'll try to add to it monthly 2025-04-05 · 18 pts ·
r/tressless
Thoughts on this 2-deoxy-D-ribose Topical? 2024-07-28 · 26 pts ·
r/tressless
| ||||||
| MicroRNA Therapy miR-218-5p | Preclinical | Topical | ||||
CompanyVarious (Research) Statusresearch Est. Release2029+ MechanismGene Expression Modulation SummaryResearch showing specific microRNAs can trigger significant hair regrowth in mice by softening stiffened stem cells. Northwestern's June 2023 study is the most recent. Promising but very early - years from human trials. LatestNorthwestern study (June 2023) showed softening stem cells via miR-205 restored hair growth in aged mice. Still preclinical, no human trials announced. | ||||||
| Exosomes | Preclinical | Injectable | ||||
CompanyVarious Statusresearch Est. Release2029+ MechanismExtracellular Vesicle Signaling SummaryExtracellular vesicles that carry growth factors and signaling molecules. Early studies show potential for stimulating hair growth. Still very experimental with no standardized protocols or advanced trials. LatestStill in pilot and preclinical studies. No advanced clinical phase expected before 2026. | ||||||
| Oleic Acid Serum | Preclinical | Topical | ||||
CompanyNational Taiwan University Statusresearch Est. ReleaseTBD MechanismHair Follicle Stem Cell Activation via Fatty Acid Metabolism SummarySerum using monounsaturated fatty acids (oleic acid, palmitoleic acid) dissolved in alcohol. Developed by Prof. Sung-Jan Lin at NTU. Activates hair follicle stem cells by mimicking the fat breakdown that occurs during skin healing. No DHT involvement - completely different pathway. Promising mouse data but years from human validation. LatestPublished in Cell Metabolism Oct 2025. Mouse studies showed hair regrowth in 20 days. Professor Lin self-tested on leg with results in 3 weeks. Human scalp trials planned, no timeline. Reddit (3)Where to buy Oleic acid, Palmitoleic acid and anhydrous ethanol? 2025-11-09 · 4 pts ·
r/tressless
Uh oh! 20 days?! Could it be so LOL 2025-10-28 · 784 pts ·
r/tressless
Taiwan scientists used naturally derived fatty acids serum to regrow hairs (in mice) 2025-10-27 · 94 pts ·
r/tressless
| ||||||
| Bee Venom (Melittin) Apitoxin | Preclinical | Topical | ||||
CompanyVarious (Research) Statusresearch Est. ReleaseTBD MechanismIGF-1/VEGF Upregulation + Controlled Irritation SummaryMouse studies comparing 0.001% bee venom to 2% minoxidil showed bee venom outperformed in regrowth speed. Proposed mechanism: melittin increases IGF-1 and VEGF around follicles, reduces inflammation, creates controlled irritation similar to microneedling. Major caveat: severe allergic reactions possible. No human trials, purely animal data. LatestMouse studies showed 0.001% bee venom outperformed 2% minoxidil in regrowth speed. No human trials. Allergy risk is major concern. | ||||||
| Hair Cloning | Preclinical | Cell Therapy | ||||
CompanyStemson Therapeutics Statusdiscontinued MechanismiPSC-derived Hair Follicle Cells SummaryWas the leading company pursuing iPSC-derived hair follicle regeneration - the 'holy grail' of unlimited donor hair. Shut down in Dec 2024 before reaching human trials. Yunce Medical (China) is now pursuing similar technology. LatestCompany shut down Dec 2024. Was the leading hair cloning research company in the US. | ||||||
FDA-approved or widely used for androgenetic alopecia.
5-alpha Reductase Inhibitor (Type II)
Gold standard DHT blocker. Blocks ~70% of DHT. FDA approved for AGA. Well-studied, effective for most. Some report sexual side effects (1-2%).
5-alpha Reductase Inhibitor (Type I & II)
Stronger than finasteride - blocks ~90% of DHT. FDA approved for BPH, used off-label for AGA. Often used when fin alone isn't enough.
Potassium Channel Opener (Vasodilator)
Stimulates hair growth via increased blood flow. Works independently of DHT. Topical OTC or oral (off-label, more effective). Warning: toxic to cats.
Wound Healing / Wnt Pathway Activation
Creates micro-wounds that stimulate healing response and Wnt signaling. Often used with minoxidil to enhance absorption. Weekly at 1.5mm depth.